Iacopino V J, Compton S, Fitzpatrick T, Ramwell P, Rose J, Kot P
J Pharmacol Exp Ther. 1984 Jun;229(3):654-7.
The isolated rat lung was used to study both the effect of leukotriene C4 on pulmonary perfusion pressure and the synthesis and release of cyclooxygenase products in the pulmonary circulation. A cell-free perfusate was passed only once through the pulmonary circulation or was recirculated. During single transit, leukotriene C4 produced dose-dependent increases in pulmonary perfusion pressure that were abolished by FPL-55712, a leukotriene receptor antagonist, but were not altered significantly by indomethacin. The duration of the pulmonary pressor response to leukotriene C4 was markedly prolonged during recirculation compared to single transit. Leukotriene C4 also induced dose-dependent increases in effluent levels of 6-keto-prostaglandin F1 alpha and thromboxane B2 that were attenuated by indomethacin or FPL-55712 pretreatment. We conclude that leukotriene C4 directly constricts the pulmonary vasculature independent of cyclooxygenase products, is not rapidly degraded by the pulmonary circulation and stimulates the release of cyclooxygenase products in the pulmonary circulation that can be attenuated by pretreatment with indomethacin or FPL-55712.
分离的大鼠肺脏被用于研究白三烯C4对肺灌注压的影响以及肺循环中环氧合酶产物的合成与释放。无细胞灌注液单次通过肺循环或进行再循环。在单次通过时,白三烯C4使肺灌注压呈剂量依赖性升高,这种升高被白三烯受体拮抗剂FPL-55712消除,但吲哚美辛未使其发生显著改变。与单次通过相比,再循环期间白三烯C4引起的肺升压反应持续时间明显延长。白三烯C4还使6-酮-前列腺素F1α和血栓素B2的流出水平呈剂量依赖性升高,吲哚美辛或FPL-55712预处理可使其减弱。我们得出结论,白三烯C4直接收缩肺血管,不依赖环氧合酶产物,不会被肺循环快速降解,并刺激肺循环中环氧合酶产物的释放,吲哚美辛或FPL-55712预处理可使其减弱。